Nathan Mathewson, PhD
About Nathan Mathewson, PhD
Nathan Mathewson, PhD, serves as the Cell Therapy Lead at Asher Biotherapeutics in South San Francisco, California, where he has worked since 2021. He has extensive experience in cancer immunology, having held various academic and research positions at institutions such as the University of Michigan Medical School and Dana-Farber Cancer Institute.
Work at Asher Biotherapeutics
Nathan Mathewson serves as the Cell Therapy Lead at Asher Biotherapeutics, a role he has held since 2021. Based in South San Francisco, California, he focuses on advancing cell therapy initiatives within the organization. His work involves the development and application of innovative therapies aimed at improving patient outcomes in oncology.
Education and Expertise
Nathan Mathewson earned his Doctor of Philosophy (PhD) in Immunology from the University of Michigan Medical School, where he studied from 2010 to 2015. His academic background provides a strong foundation in immunological principles, which he applies in his current research and professional roles. His expertise encompasses engineered cell therapies and cytokine applications in cancer treatment.
Background in Cancer Research
Nathan Mathewson has extensive experience in cancer research, having worked at several prestigious institutions. He was a Graduate Student at the University of Michigan Medical School, focusing on cancer research from 2010 to 2015. He later served as a Fellow in the Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute from 2015 to 2020, and as an Instructor in Cancer Immunology at Dana-Farber from 2020 to 2021.
Research Contributions
Nathan Mathewson has contributed significantly to the field of cancer immunotherapy. His research includes the development of engineered cell surface tag-targeted IL-2 and IL-21 to enhance CAR-T anti-tumor activity. He has also worked on the selective support of CAR-T cell therapies through cis-targeted cytokines, aiming to improve therapeutic efficacy in cancer treatment.
Professional Involvement
In addition to his work at Asher Biotherapeutics, Nathan Mathewson has served as a Scientific Advisor at Immunitas Therapeutics since 2019. He actively participates in professional conferences, including the American Society of Hematology conference in December 2022, where he engages with peers and shares insights on advancements in hematology and oncology.